USANA Health Sciences (USNA) reported Q1 adjusted earnings late Tuesday of $0.73 per diluted share, down from $0.86 a year earlier.
A single analyst polled by FactSet expected $0.70.
Net sales for the quarter ended March 29 were $249.5 million, up from $227.8 million a year earlier.
A lone analyst surveyed by FactSet expected $243 million.
The company reiterated its full-year 2025 adjusted diluted EPS outlook of $2.35 to $3 and net sales guidance of $920 million to $1 billion. A single analyst polled by FactSet expects adjusted diluted EPS of $2.59 and net sales of $941.6 million.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。